Topical tacrolimus for oral cicatricial pemphigoid [2]

Clinical and Experimental Dermatology

Volumn 29, Issue 6, 2004, Pages 674-676

  Assmann, T ^a   Becker, J ^a   Ruzicka, T ^a   Megahed, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOGLOBULIN; RETINOID; TACROLIMUS;

AGED; BLISTER; BURNING SENSATION; CASE REPORT; CHEEK MUCOSA; FEMALE; GINGIVA; HUMAN; INFECTION; LETTER; MALE; MOUTH LESION; MOUTH MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; OSTEOPOROSIS; PRIORITY JOURNAL; SEPSIS;

ADMINISTRATION, TOPICAL; AGED; FEMALE; GINGIVAL DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MOUTH DISEASES; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; TACROLIMUS;

EID: 9644273746     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01619.x     Document Type: Letter

References (10)

1. Ahmed AR, Kurgis BS, Rogers RS III Cicatricial pemphigoid. J Am Acad Dermatol 1991; 24: 987-1001.
2. Regezi J, Sciubba J, Jordan R. Vesiculo-bullous diseases. In: Regezi, J, Sciubba, J, Jordan, R, eds. Oral Pathology: Clinical Pathologic Correlations, 4th edn. St Louis, Saunders, 2004, 1-21.
3. Lamey PJ, Rees TD, Binnie WH, Rankin KV. Mucous membrane pemphigoid. Treatment experience at two institutions. Oral Surg Oral Med Oral Pathol 1992; 74: 50-3.
4. Sami N, Bhol KC, Ahmed AR. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid. Clin Immunol 2002; 102: 59-67.
5. Hall VC, Liesegang TJ, Kostick DA, Lookingbill DP. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003; 139: 1083-4.
6. Caproni M, Calzolari A, Salvatore E et al. Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid. J Oral Pathol Med 2003; 32: 34-40.
7. Megahed M. Cicatricial pemphigoid. In: Megahed M, ed.). Histopathology of Blistering Diseases. Heidelberg; Springer-Verlag, 2004: 182-97.
8. Homey B, Assmann T, Vohr HW et al. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J Immunol 1998; 160: 5331-40.
9. Assmann T, Homey B, Ruzicka T. Topical tacrolimus for the treatment of inflammatory skin diseases. Expert Opin Pharmacother 2001; 2: 1167-75.
10. Reitamo S, Rissanen J, Remitz A et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111: 396-8.